key: cord-0975731-y4c9h65r
authors: Fosam, Andin; Yuditskaya, Susan; Sarcone, Camila; Grewal, Shivraj; Fan, Hubert; Muniyappa, Ranganath
title: Minimal Model–Derived Insulin Sensitivity Index Underestimates Insulin Sensitivity in Black Americans
date: 2021-09-14
journal: Diabetes Care
DOI: 10.2337/dc21-0490
sha: 26bb66dfc08ca9c249ce537179fb7fb86109f251
doc_id: 975731
cord_uid: y4c9h65r

OBJECTIVE: To examine the ethnic differences in insulin sensitivity (S(I)) as measured by the minimal model approach (S(I)-MM) and the reference method, the euglycemic-hyperinsulinemic clamp (EHC). RESEARCH DESIGN AND METHODS: In a prospective study design, thirty Black Americans (BA) were age, sex, and BMI matched with non-Hispanic Whites (NHW). Participants underwent frequently sampled intravenous tolerance test (FSIVGTT) and EHC on 2 separate days during a single visit. RESULTS: S(I)-MM values were significantly lower in BA when compared with NHW (0.035 ± 0.025 vs. 0.058 ± 0.036 [dL/min]/[μU/mL]; P = 0.003). However, there were no ethnic differences in S(I) measured by EHC (0.028 ± 0.012 vs. 0.035 ± 0.019 [dL/min]/[μU/mL]; P = 0.18). CONCLUSIONS: S(I)-MM systematically underestimates S(I) in BA when compared with NHW. These findings suggest that studies inferring lower S(I) in BA based on FSIVGTT and S(I)-MM should be interpreted cautiously.

glucose and insulin concentrations (3) . Whether ethnicity similarly affects the reliability of S I -MM to accurately predict S I as determined by EHC is unknown. In this study, we examined the ethnic differences in the ability of S I -MM to predict S I as measured by EHC.

This study protocol was approved by the Institutional Review Board of the National Institute of Diabetes and Digestive and Kidney Diseases and was conducted at the Clinical Research Center, National Institutes of Health, in Bethesda, Maryland. Thirty BA and 30 NHW, matched for age, sex, and BMI, were prospectively enrolled in the Study of the Phenotype of Overweight and Obese Adults (ClinicalTrials.gov identifier NCT00428987). Written informed consent was attained from all participants. Participants were admitted for a 3-night visit to the National Institutes of Health Metabolic Research Unit. After an overnight fast, S I was evaluated by the EHC (glucose disposal rate [GDR]) and insulin-modified FSIVGTT (S I -MM) on different days in random order as previously described (4) . The rate of glucose disposal (M), a measure of S I was defined as the average of the glucose infusion rate during the steady state (GDR in milligrams per minute) corrected for estimated metabolic body size. The steady-state period of the clamp was defined as a $20-min period, 90 min after the initiation of the clamp, where the coefficient of variation for plasma glucose and glucose infusion rate was <5%. Prior to EHC, basal hepatic glucose production (HGP) and hepatic insulin resistance index were measured by using a stable isotope tracer (4) . Because of the interruption in pharmacy compounding services and access to tracers, we could conduct tracer studies in only 43 individuals (BA n = 21; NHW n = 22). In addition, we measured circulating IGF binding protein 1 (IGFBP-1), a marker for hepatic S I . Minimal model analysis of the FSIVGTT was used to estimate glucose effectiveness (Sg) and S I -MM values as previously described using MINMOD software (version 6.02) (MinMOD Millenium, Los Angeles, CA) (4). Precision of parameter estimates from S I -MM was assessed by fractional SD. Mean fractional SD of parameter estimates were <10%. Measures of S I from EHC (Sc-Clamp) and S I -MM (Sc-MM), specifically, change in glucose clearance per change in plasma insulin concentration, were expressed in the same units as originally described (5) . A model-independent index of S I (calculated S I ) was calculated and is related to KG/AUC D (6) . KG is the rate of glucose disappearance (slope of log glucose), and AUC D is defined as the dynamic area under the insulin curve in FSIVGTT (0-50 min).

Variables are expressed as mean ± SD. Comparisons between groups were assessed by the independent unpaired t test or Wilcoxon-Mann-Whitney test. A P value <0.05 was considered statistically significant. Data were analyzed with JMP software (version 13.0) (SAS Institute, Cary, NC) and GraphPad Prism 7 software (GraphPad Software, Inc, La Jolla, CA).

Percentage body fat, total body fat, fatfree mass, and fasting plasma glucose and insulin concentrations were similar between the groups (Table 1) . BA had a significantly greater A1C than NHW. Six BA and three NHW had impaired fasting glucose (P 5 0.27). Fifteen BA and four NHW had prediabetes based on A1C levels (P 5 0.002). QUICKI, a surrogate measure of S I based on fasting glucose and insulin concentrations, was not significantly different between the groups (P 5 0.07) ( Table 1) . Direct measurement of S I by EHC was similar between NHW and BA (Table 1) . However, S I -MM values were significantly lower in BA when compared with NHW (Table 1) . Similarly, when these parameters were expressed in the same units, Sc-Clamp was not significantly different between the groups, but Sc-MM was lower in BA (Table 1) . Simple linear regression analyses revealed a modest but significant relationship between log-transformed S I -MM and GDR values in BA (r 5 0.44; P 5 0.04) and NHW (r 5 0.62; P 5 0.003). Indeed, Deming regression analysis, which assumes measurement error in Sc-MM and Sc-Clamp, showed a fixed bias (y-intercept) between ethnic groups (P 5 0.002). Indeed, a factor of 1.65 applied to Sc-MM in BA (Sc-MM * 1.65) corrects the bias between the ethnic groups. Like S I -MM and Sc-MM values, calculated S I was lower in BA (BA 0.90 ± 0.58; NHW 1.41 ± 0.95 10 À4 Á [mU/mL] À1 Á min À1 ; P 5 0.04). We did not observe any significant ethnic differences in estimated whole-body glucose effectiveness by clamp (BA 0.037 ± 0.016; NHW 0.033 ± 0.020 dL Á min À1 Á kg À1 ; P 5 0.40) or IVGTT (BA 0.019 ± 0.008; NHW 0.015 ± 0.006 min À1 ; P 5 0.12). In a subset of our cohort, hepatic insulin resistance index was not different between the groups (BA 6.81 ± 2.77; NHW 6.82 ± 2.91 [mg/kg/ min] Á [ng/mL]; P 5 0.94). Concentrations of circulating IGFBP-1 were similar (BA 11.7 ± 9.4; NHW 12.3 ± 6.7 ng/ mL; P 5 0.26).

In this study, despite similar M and Sc-Clamp in both groups, S I determined by S I -MM was $40% lower in BA. Sc-MM and Sc-Clamp are comparable, but not equivalent. S I is a measure of insulinmediated glucose uptake and inhibition of HGP. In normal individuals, only $17% of S I is due to insulin inhibition of HGP, while the rest is due to insulinstimulated glucose disposal (5). Nevertheless, measures of hepatic S I were similar in both groups and thus do not explicate the lower S I from S I -MM in BA. GDR from the clamp represents peripheral insulin-and glucose-dependent glucose disposal (glucose effectiveness). We did not observe any significant difference in estimated whole-body glucose effectiveness measures using the clamp or S I -MM. These results suggest that there is no ethnic bias in the measures of glucose disposal during EHC.

In S I -MM, S I is mathematically represented as the partial derivative of glucose disappearance on glucose insulin. Because of the inverse relationship between S I and insulin concentrations, the model likely underestimates S I in individuals who display higher insulin response, especially first-phase insulin secretion (AIR) ( Table 1 ). The robust AIR (approximately 2-fold) and impaired clearance of insulin (337 ± 90 vs. 432 ± 208 mL Á m À2 Á min À1 ; P 5 0.01) in BA may thus play a role in affecting the lumped parameters in the model and estimation of S I (7). Indeed, we recently reported that in simulated FSIVGTT, S I -MM underestimated S I because of its inverse relationship care.diabetesjournals.org Fosam and Associates with AIR. This underestimation was context dependent and observed only when high AIR was the result of an increased size of the rapidly releasable pool of insulin (7) . Consistent with our results, other studies using EHC have not demonstrated differences in S I between BA and NHW (3, (8) (9) (10) . In a systematic review of S I -MM studies, BA were more likely to demonstrate lower S I (2). However, presented here is the first prospectively designed study to demonstrate lower S I in BA by FSIVGT, but not EHC, in age-, sex-, and BMI-matched ethnic cohorts. Pisprasert et al. (3) showed that BA were more insulin resistant when assessed by the Matsuda index, HOMA for insulin resistance, and fasting insulin level, despite similar S I levels by EHC. These studies together question the reliability of surrogate measures in assessing S I in BA.

Strengths of our study include the prospective study design, BMI matching, and use of the gold-standard EHC technique to compare S I . Limitations include self-reporting of ethnicity and small sample size. Nevertheless, a priori sample size calculation suggested that a sample size of n 5 30 was sufficient to detect a 20% difference in S I (by EHC) between groups at a power of 80% and a type I error of 5%.

In conclusion, our results suggest ethnic differences exist in the predictive ability of S I -MM, and studies inferring lower S I in BA without diabetes based on FSIVGTT and minimal modeling should be interpreted cautiously.

Funding. This work was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. A.F. researched the data, created the figures, and co-wrote the manuscript. S.Y. participated in the study design, performed the study, researched the data, and edited the manuscript. C.S., S.G., and H.F. researched the data and reviewed and edited the manuscript. R.M. designed the study, obtained funding, performed the study, and co-wrote the manuscript. R.M. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Data are presented as arithmetic mean ± SD. *An unpaired, two-tailed Student t test (or Mann-Whitney U test for values that were not normally distributed) was used to test differences between ethnic groups. P values indicate significance for comparisons between ethnic groups. †Sc-MM is obtained by multiplying S I -MM by V D , where V D is the apparent volume of distribution of glucose and is equal to the ratio of the glucose dose to the increment in plasma glucose during FSIVGTT. ‡Sc-Clamp was defined as GDR/(G Â DI), where G is steady-state blood glucose concentration (mg/dL), and DI is the difference between basal and steady-state plasma insulin concentrations (mU/mL).

Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study

Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis

Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans

Increased b-cell responsivity independent of insulin sensitivity in healthy African American adults

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics

When MINMOD artifactually interprets strong insulin secretion as weak insulin action

Exaggerated insulin secretion in Pima Indians and African-Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians

Glucoregulatory function among African Americans and European Americans with normal or prediabetic hemoglobin A1c levels

Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat